ABVX
Price
$88.03
Change
+$2.48 (+2.90%)
Updated
Sep 5 closing price
Capitalization
6.74B
One day until earnings call
VYNE
Price
$0.30
Change
-$0.01 (-3.23%)
Updated
Sep 5 closing price
Capitalization
7.62M
Interact to see
Advertisement

ABVX vs VYNE

Header iconABVX vs VYNE Comparison
Open Charts ABVX vs VYNEBanner chart's image
Abivax SA
Price$88.03
Change+$2.48 (+2.90%)
Volume$3.2M
Capitalization6.74B
VYNE Therapeutics
Price$0.30
Change-$0.01 (-3.23%)
Volume$2.09M
Capitalization7.62M
ABVX vs VYNE Comparison Chart in %
Loading...
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVX vs. VYNE commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Hold and VYNE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (ABVX: $88.03 vs. VYNE: $0.30)
Brand notoriety: ABVX and VYNE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 164% vs. VYNE: 84%
Market capitalization -- ABVX: $6.74B vs. VYNE: $7.62M
ABVX [@Biotechnology] is valued at $6.74B. VYNE’s [@Biotechnology] market capitalization is $7.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileVYNE’s FA Score has 2 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • VYNE’s FA Score: 2 green, 3 red.
According to our system of comparison, VYNE is a better buy in the long-term than ABVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 3 TA indicator(s) are bullish while VYNE’s TA Score has 4 bullish TA indicator(s).

  • ABVX’s TA Score: 3 bullish, 4 bearish.
  • VYNE’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VYNE is a better buy in the short-term than ABVX.

Price Growth

ABVX (@Biotechnology) experienced а +8.64% price change this week, while VYNE (@Biotechnology) price change was -6.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ABVX is expected to report earnings on Sep 08, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABVX($6.74B) has a higher market cap than VYNE($7.62M). ABVX YTD gains are higher at: 1102.596 vs. VYNE (-91.069). VYNE has higher annual earnings (EBITDA): -42.58M vs. ABVX (-170.04M). ABVX has more cash in the bank: 104M vs. VYNE (39.6M). VYNE has less debt than ABVX: VYNE (25K) vs ABVX (92.6M). VYNE has higher revenues than ABVX: VYNE (476K) vs ABVX (0).
ABVXVYNEABVX / VYNE
Capitalization6.74B7.62M88,427%
EBITDA-170.04M-42.58M399%
Gain YTD1102.596-91.069-1,211%
P/E RatioN/A0.71-
Revenue0476K-
Total Cash104M39.6M263%
Total Debt92.6M25K370,400%
FUNDAMENTALS RATINGS
VYNE: Fundamental Ratings
VYNE
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABVXVYNE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 5 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 19 days ago
86%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DRECX41.860.50
+1.21%
Davis Real Estate C
HFMDX23.200.10
+0.43%
Hennessy Cornerstone Mid Cap 30 Inv
GFACX73.450.17
+0.23%
American Funds Growth Fund of Amer C
FRAAX60.81N/A
N/A
Franklin Growth Opportunities Adv
DNLCX54.49-0.01
-0.02%
BNY Mellon Active MidCap C

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with IMNN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+2.90%
IMNN - ABVX
57%
Loosely correlated
+0.61%
CLSD - ABVX
51%
Loosely correlated
-1.23%
ANEB - ABVX
46%
Loosely correlated
-0.42%
MLTX - ABVX
38%
Loosely correlated
-0.47%
XENE - ABVX
38%
Loosely correlated
+1.48%
More

VYNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYNE has been loosely correlated with NEVPF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VYNE jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYNE
1D Price
Change %
VYNE100%
-3.64%
NEVPF - VYNE
52%
Loosely correlated
N/A
SYRE - VYNE
36%
Loosely correlated
+0.06%
ABVX - VYNE
34%
Loosely correlated
+2.90%
EYPT - VYNE
33%
Loosely correlated
+17.93%
GLTO - VYNE
30%
Poorly correlated
+0.33%
More